A23187 |
A calcium ionophore and a microbial metabolite; induces calcium overload a… |
1 mg |
11016-1 |
More Info
|
A23187 |
A calcium ionophore and a microbial metabolite; induces calcium overload a… |
10 mg |
11016-10 |
More Info
|
A23187 |
A calcium ionophore and a microbial metabolite; induces calcium overload a… |
25 mg |
11016-25 |
More Info
|
A23187 |
A calcium ionophore and a microbial metabolite; induces calcium overload a… |
5 mg |
11016-5 |
More Info
|
A286982 |
An inhibitor that blocks the integrin-ligand interaction between LFA-1 and… |
10 mg |
27646-10 |
More Info
|
A286982 |
An inhibitor that blocks the integrin-ligand interaction between LFA-1 and… |
25 mg |
27646-25 |
More Info
|
A286982 |
An inhibitor that blocks the integrin-ligand interaction between LFA-1 and… |
5 mg |
27646-5 |
More Info
|
A286982 |
An inhibitor that blocks the integrin-ligand interaction between LFA-1 and… |
50 mg |
27646-50 |
More Info
|
A-317491 |
A P2X3 and P2X2 / 3 receptor antagonist (Kis = 22-92 nM in a calcium influ… |
1 mg |
19256-1 |
More Info
|
A-317491 |
A P2X3 and P2X2 / 3 receptor antagonist (Kis = 22-92 nM in a calcium influ… |
10 mg |
19256-10 |
More Info
|
A-317491 |
A P2X3 and P2X2 / 3 receptor antagonist (Kis = 22-92 nM in a calcium influ… |
25 mg |
19256-25 |
More Info
|
A-317491 |
A P2X3 and P2X2 / 3 receptor antagonist (Kis = 22-92 nM in a calcium influ… |
5 mg |
19256-5 |
More Info
|
A-366 |
A potent, peptide-competitive inhibitor of the lysine methyltransferase G9… |
10 mg |
16081-10 |
More Info
|
A-366 |
A potent, peptide-competitive inhibitor of the lysine methyltransferase G9… |
5 mg |
16081-5 |
More Info
|
A-366 |
A potent, peptide-competitive inhibitor of the lysine methyltransferase G9… |
50 mg |
16081-50 |
More Info
|
A-419259 |
An inhibitor of Src family kinases, including Src, LCK, Lyn, and Hck (IC50… |
1 mg |
25605-1 |
More Info
|
A-419259 |
An inhibitor of Src family kinases, including Src, LCK, Lyn, and Hck (IC50… |
10 mg |
25605-10 |
More Info
|
A-419259 |
An inhibitor of Src family kinases, including Src, LCK, Lyn, and Hck (IC50… |
5 mg |
25605-5 |
More Info
|
A-443654 |
A pan Akt inhibitor (Ki = 160 pmol / L for all three isoforms) that interf… |
1 mg |
16499-1 |
More Info
|
A-443654 |
A pan Akt inhibitor (Ki = 160 pmol / L for all three isoforms) that interf… |
5 mg |
16499-5 |
More Info
|
A-443654 |
A pan Akt inhibitor (Ki = 160 pmol / L for all three isoforms) that interf… |
500 µg |
16499-500 |
More Info
|
A-484954 |
An eEF-2K inhibitor; reduces eEF-2K autophosphorylation in various cancer… |
1 mg |
28279-1 |
More Info
|
A-484954 |
An eEF-2K inhibitor; reduces eEF-2K autophosphorylation in various cancer… |
10 mg |
28279-10 |
More Info
|
A-484954 |
An eEF-2K inhibitor; reduces eEF-2K autophosphorylation in various cancer… |
25 mg |
28279-25 |
More Info
|
A-484954 |
An eEF-2K inhibitor; reduces eEF-2K autophosphorylation in various cancer… |
5 mg |
28279-5 |
More Info
|
A-485 |
A p300 / CBP inhibitor (IC50 = 60 nM); decreases H3K27Ac levels in PC3 cel… |
1 mg |
24119-1 |
More Info
|
A-485 |
A p300 / CBP inhibitor (IC50 = 60 nM); decreases H3K27Ac levels in PC3 cel… |
10 mg |
24119-10 |
More Info
|
A-485 |
A p300 / CBP inhibitor (IC50 = 60 nM); decreases H3K27Ac levels in PC3 cel… |
25 mg |
24119-25 |
More Info
|
A-485 |
A p300 / CBP inhibitor (IC50 = 60 nM); decreases H3K27Ac levels in PC3 cel… |
5 mg |
24119-5 |
More Info
|
A-61603 |
A selective α1A-adrenergic receptor agonist that is at least 35-fold… |
1 mg |
17358-1 |
More Info
|
A-61603 |
A selective α1A-adrenergic receptor agonist that is at least 35-fold… |
10 mg |
17358-10 |
More Info
|
A-61603 |
A selective α1A-adrenergic receptor agonist that is at least 35-fold… |
5 mg |
17358-5 |
More Info
|
A-66 |
A potent, selective inhibitor of the PI3K isoform p110α (IC50 = 32 n… |
1 mg |
17382-1 |
More Info
|
A-66 |
A potent, selective inhibitor of the PI3K isoform p110α (IC50 = 32 n… |
10 mg |
17382-10 |
More Info
|
A-66 |
A potent, selective inhibitor of the PI3K isoform p110α (IC50 = 32 n… |
25 mg |
17382-25 |
More Info
|
A-66 |
A potent, selective inhibitor of the PI3K isoform p110α (IC50 = 32 n… |
5 mg |
17382-5 |
More Info
|
A-674563 |
An orally available, reversible inhibitor of Akt (Ki = 11 nM for Akt1); al… |
1 mg |
18715-1 |
More Info
|
A-674563 |
An orally available, reversible inhibitor of Akt (Ki = 11 nM for Akt1); al… |
10 mg |
18715-10 |
More Info
|
A-674563 |
An orally available, reversible inhibitor of Akt (Ki = 11 nM for Akt1); al… |
5 mg |
18715-5 |
More Info
|
A-674563 |
An orally available, reversible inhibitor of Akt (Ki = 11 nM for Akt1); al… |
500 µg |
18715-500 |
More Info
|
A6770 |
An inhibitor of S1P lyase; induces accumulation of [3H]dhS1P in IT-79MTNC3… |
1 mg |
29972-1 |
More Info
|
A6770 |
An inhibitor of S1P lyase; induces accumulation of [3H]dhS1P in IT-79MTNC3… |
10 mg |
29972-10 |
More Info
|
A6770 |
An inhibitor of S1P lyase; induces accumulation of [3H]dhS1P in IT-79MTNC3… |
5 mg |
29972-5 |
More Info
|
A6770 |
An inhibitor of S1P lyase; induces accumulation of [3H]dhS1P in IT-79MTNC3… |
500 µg |
29972-500 |
More Info
|
A-740003 |
A selective P2X7 antagonist (IC50s = 40 and 18 nM for human and rat recept… |
1 mg |
21256-1 |
More Info
|
A-740003 |
A selective P2X7 antagonist (IC50s = 40 and 18 nM for human and rat recept… |
10 mg |
21256-10 |
More Info
|
A-740003 |
A selective P2X7 antagonist (IC50s = 40 and 18 nM for human and rat recept… |
25 mg |
21256-25 |
More Info
|
A-740003 |
A selective P2X7 antagonist (IC50s = 40 and 18 nM for human and rat recept… |
5 mg |
21256-5 |
More Info
|
A-769662 |
A direct activator of AMPK (EC50 = 116 nM in a cell-free assay); allosteri… |
10 mg |
11900-10 |
More Info
|
A-769662 |
A direct activator of AMPK (EC50 = 116 nM in a cell-free assay); allosteri… |
25 mg |
11900-25 |
More Info
|